Type(s) of Cancer
Leukemia/Lymphoma
Leukemia/Lymphoma
Study Phase
Phase 2B
Study Completion Date
2008-10
2008-10
NCT00301821Uploaded 09-11-2019
Access via NCI by Request
PDS UID: nci-data-372
A Phase II Study of Epratuzumab, Rituximab (ER)-CHOP for Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
Files: NCT00301821-D2![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-csv.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
Data DictionaryNCT00301821-D2-Data-Dictionary_0.pdf
![](/projectdatasphere/Images/icons/icon-csv.png)
DATANCT00301821-D2-Dataset_0.csv
![](/projectdatasphere/Images/icons/icon-pdf.png)
OTHERREADME.pdf
Files: NCT00301821-D1![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-csv.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
Data DictionaryNCT00301821-D1-Data-Dictionary_0.pdf
![](/projectdatasphere/Images/icons/icon-csv.png)
DATANCT00301821-D1-Dataset.csv
![](/projectdatasphere/Images/icons/icon-pdf.png)
OTHERREADME.pdf